Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008945', 'term': 'Mitral Valve Prolapse'}], 'ancestors': [{'id': 'D016127', 'term': 'Heart Valve Prolapse'}, {'id': 'D006349', 'term': 'Heart Valve Diseases'}, {'id': 'D006331', 'term': 'Heart Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR'], 'maskingDescription': 'The PRIMARY trial is an open-label trial. As in the parent trial, clinical investigators, and coordinators, however, will be blinded to all overall outcome data in the ancillary study.'}, 'primaryPurpose': 'BASIC_SCIENCE', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 250}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-10-16', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-08', 'completionDateStruct': {'date': '2027-06-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-08-14', 'studyFirstSubmitDate': '2025-07-22', 'studyFirstSubmitQcDate': '2025-08-01', 'lastUpdatePostDateStruct': {'date': '2025-08-19', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2025-08-05', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2027-06-30', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Presence of Myocardial Fibrosis', 'timeFrame': '1 year post index procedure.', 'description': "Myocardial fibrosis is the buildup of excess fibrous connective tissue in the heart muscle often resulting from chronic injury or stress. It can impair the heart's ability to contract and relax properly leading to reduced cardiac function."}, {'measure': 'Presence of Ventricular Arrythmia', 'timeFrame': '1 year post index procedure.', 'description': 'A ventricular arrhythmia is an abnormal heart rhythm that starts in the lower chambers of the heart (the ventricles). It can cause the heart to beat too fast, which may reduce blood flow to the body and, in some cases, be life-threatening.'}, {'measure': 'Proteomics', 'timeFrame': '1 year post index procedure.', 'description': 'Proteomics is the large-scale study of proteins, which are essential molecules that carry out most functions in the body. By analyzing proteins in tissues or fluids, scientists can better understand diseases, identify biomarkers, and discover new treatment targets.'}], 'secondaryOutcomes': [{'measure': 'Computational and Predictive Models of Treatment Outcome', 'timeFrame': '1 year post index procedure.', 'description': 'specific treatment. These tools help doctors make more personalized and effective care decisions based on patterns found in large sets of medical information.'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'keywords': ['Mitral valve repair (MVr)', 'Transcatheter-edge-to-edge-repair (TEER)', 'Cardiac magnetic resonance imaging (CMR)', 'ZioPatch monitoring', 'Heart biopsy'], 'conditions': ['Mitral Valve Prolapse', 'Left Ventricular Fibrosis', 'Ventricular Arrhythmias']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://clinicaltrials.gov/study/NCT05051033', 'label': 'PRIMARY Trial'}]}, 'descriptionModule': {'briefSummary': 'The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular (LV) myocardial structure and function, and, thereby, predispose to arrhythmias and sudden death. Such insights are key to identifying interventions to reduce the long-term sequelae of heart failure (HF) and arrhythmias, as well as delineate optimal therapeutic approaches for different patient sub-groups.', 'detailedDescription': "This is an ancillary study of a multicenter randomized clinical trial comparing MVr to TEER for degenerative mitral regurgitation (MR) involving up to 250 patients from the parent trial. All patients will receive rhythm monitoring, up to 200 patients will receive pre/post intervention CMR, all patients in the parent trial will undergo a transthoracic echocardiogram (TTE) (as part of the randomized controlled trial (RCT)), and 60 surgical patients will undergo tissue biopsies. The study is being conducted in highly experienced clinical centers in the U.S., Canada, Germany, the U.K. and Spain. The estimated enrollment period is 12-18 months. Outcomes will be measured from baseline to 12 months after randomization.\n\nThis mechanistic ancillary study has the following aims:\n\n1. To compare the impact of MVr and TEER on disordered ventricular biomechanics and myocardial fibrosis that predispose to ventricular arrhythmias, using speckle tracking strain echocardiography, cardiac magnetic resonance imaging (CMR), and rhythm monitoring pre- and post-mitral valve (MV) intervention. The research team hypothesize's that a treatment strategy that more effectively and durably reduces MVP and MR will lead to improved ventricular mechanics, limit progression of myocardial fibrosis and decrease the burden of ventricular arrhythmias and HF.\n2. To compare the impact of MVr and TEER on recurrent/residual MR, LV and left atrial (LA) reverse remodeling with baseline and 1-year post-intervention CMR, and to use quantitative CMR myocardial tissue phenotyping as a predictor of response to MVr and TEER.\n3. To construct functional pre-operative CMR fingerprints that recapitulate the mechanical state of the heart to develop individualized computational models, which will be altered in silico based on the proposed treatment plan, to predict patients' response to therapy. These results will be validated against post-operative outcome data to test the validity of this approach for predicting treatment response.\n4. To explore the relationships among gene products, structural variables, and post-operative clinical outcomes, including reverse remodeling, using tissue obtained at surgery from ventricular myocardium."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '60 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients who meet all eligibility criteria and are randomized in the parent PRIMARY trial.\n* For the ancillary biospecimen study, patients who are randomized to MVr in the parent trial.\n\nExclusion Criteria:\n\n* Severe claustrophobia not controlled with sedation.\n* Prior adverse reaction to gadolinium administration.\n* Patients with an implantable subcutaneous cardioverter defibrillator and/or cardiac resynchronization therapy device with defibrillator may be excluded as they typically produce substantial artifacts on cardiac MRI making assessment very challenging.\n* Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies (for patients undergoing rhythm monitoring).'}, 'identificationModule': {'nctId': 'NCT07103733', 'briefTitle': 'PRIMARY Ancillary Substudy', 'organization': {'class': 'OTHER', 'fullName': 'Icahn School of Medicine at Mount Sinai'}, 'officialTitle': 'Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) Ancillary Substudy', 'orgStudyIdInfo': {'id': 'GCO 08-1078 ANC'}, 'secondaryIdInfos': [{'id': '5U01HL088942-17', 'link': 'https://reporter.nih.gov/quickSearch/5U01HL088942-17', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Mitral valve repair', 'description': 'Mitral surgery will be conducted using general anesthesia and cardiopulmonary bypass. Mitral surgery may be performed via a sternotomy or a right thoracotomy approach with or without robotic assistance.', 'interventionNames': ['Procedure: Cardiac Magnetic Resonance Imaging', 'Device: ZioPatch Monitoring', 'Procedure: Myocardial Tissue Biopsy']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Transcatheter edge-to-edge repair', 'description': 'Patients will be treated with a commercially-approved edge-to-edge mitral repair device.', 'interventionNames': ['Procedure: Cardiac Magnetic Resonance Imaging', 'Device: ZioPatch Monitoring']}], 'interventions': [{'name': 'Cardiac Magnetic Resonance Imaging', 'type': 'PROCEDURE', 'otherNames': ['CMR'], 'description': 'Non-invasive imaging test that uses powerful magnets and radio waves to create detailed pictures of the heart without using radiation.', 'armGroupLabels': ['Mitral valve repair', 'Transcatheter edge-to-edge repair']}, {'name': 'ZioPatch Monitoring', 'type': 'DEVICE', 'otherNames': ['iRhythm Monitoring'], 'description': "ZioPatch is a small, wearable heart monitor that sticks to the chest and records the heart's electrical activity continuously for up to 14 days. It helps doctors detect irregular heart rhythms (arrhythmias) without the need for bulky wires or equipment.", 'armGroupLabels': ['Mitral valve repair', 'Transcatheter edge-to-edge repair']}, {'name': 'Myocardial Tissue Biopsy', 'type': 'PROCEDURE', 'otherNames': ['Heart Bioplsy'], 'description': 'During the MVr procedure, surgeons will biopsy approximately 50 μg of tissue from the endocardial and subendocardial myocardium in the inferobasilar and control areas using a surgical rongeur.', 'armGroupLabels': ['Mitral valve repair']}]}, 'contactsLocationsModule': {'locations': [{'zip': '90033', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Edward Lozano', 'role': 'CONTACT', 'email': 'edwardlo@med.usc.edu'}, {'name': 'Vaughn Starnes, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Keck Hospital of the University of Southern California', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90048', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Vanessa Wilson', 'role': 'CONTACT', 'email': 'Vanessa.Wilson@csmns.org'}, {'name': 'Joanna Chikwe, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cedars-Sinai', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '94143', 'city': 'San Francisco', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Georgia Applegarth', 'role': 'CONTACT', 'email': 'Georgia.Applegarth@ucsf.edu'}, {'name': 'Sammy Elmariah, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of California San Francisco', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '94305', 'city': 'Stanford', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Luz Memije', 'role': 'CONTACT', 'email': 'memije16@stanford.edu'}, {'name': 'Jack Boyd, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Stanford University', 'geoPoint': {'lat': 37.42411, 'lon': -122.16608}}, {'zip': '30309', 'city': 'Atlanta', 'state': 'Georgia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Danielle Griffith', 'role': 'CONTACT', 'email': 'danielle.griffith@piedmont.org'}, {'name': 'Vinod Thourani, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Piedmont Heart Institute', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '04102', 'city': 'Portland', 'state': 'Maine', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Monica Palmeri', 'role': 'CONTACT', 'email': 'Monica.Palmeri@mainehealth.org'}, {'name': 'Robert Kramer, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Maine Medical Center', 'geoPoint': {'lat': 43.65737, 'lon': -70.2589}}, {'zip': '21287', 'city': 'Baltimore', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Zyriah Robinson', 'role': 'CONTACT'}, {'name': 'James Gammie, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Johns Hopkins Hospital', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '02114', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Patrick Udeh', 'role': 'CONTACT', 'email': 'pudeh@mgh.harvard.edu'}, {'name': 'Serguei Melnitchouk, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Massachusetts General Hospital', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48109', 'city': 'Ann Arbor', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Nicole White', 'role': 'CONTACT', 'email': 'nlaniece@med.umich.edu'}, {'name': 'Gorav Ailawadi', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Michigan Hospital', 'geoPoint': {'lat': 42.27756, 'lon': -83.74088}}, {'zip': '64111', 'city': 'Kansas City', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Diane Peterman', 'role': 'CONTACT', 'email': 'dpeterman@saint-lukes.org'}, {'name': 'Keith Allen, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Luke's Hospital of Kansas City/MidAmerica Heart and Lung Surgeons", 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '10065', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Marshagay Rodriques', 'role': 'CONTACT', 'email': 'mar4028@med.cornell.edu'}, {'name': 'Stephanie Mick, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Donald Glower', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Weill Cornell Medicine/ New York-Presbyterian Hospital', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10075', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Ameerah Ali', 'role': 'CONTACT', 'email': 'aali35@northwell.edu'}, {'name': 'Nirav Patel, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Northwell--Lenox Hill, North Shore, South Shore, Staten Island University Hospital', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '27710', 'city': 'Durham', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Kathleen Lane', 'role': 'CONTACT', 'email': 'kathleen.rohrback@duke.edu'}, {'name': 'Donald Glower, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Duke University Hospital', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Anna M Simmons', 'role': 'CONTACT', 'email': 'simmona8@ccf.org'}, {'name': 'Marc Gilinov, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cleveland Clinic', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '22908', 'city': 'Charlottesville', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Linda Bailes', 'role': 'CONTACT', 'email': 'LGS2M@uvahealth.org'}, {'name': 'John Saxon, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Virginia Medical Center', 'geoPoint': {'lat': 38.02931, 'lon': -78.47668}}, {'zip': '26506', 'city': 'Morgantown', 'state': 'West Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Josh Bombard', 'role': 'CONTACT', 'email': 'josh.bombard@wvumedicine.org'}, {'name': 'Vinay Badhwar, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'West Virginia University Hospital', 'geoPoint': {'lat': 39.62953, 'lon': -79.9559}}, {'zip': '13353', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Andreas Bader-Wölfle, RN, PhD', 'role': 'CONTACT', 'email': 'andreas.bader-woelfle@dhzc-charite.de', 'phone': '+49 (0)30-4593-2204'}, {'name': 'Volkmar Falk', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Deutsches Herzzentrum der Charité', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '04289', 'city': 'Leipzig', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Andreas Bader-Wölfle, RN, PhD', 'role': 'CONTACT', 'email': 'andreas.bader-woelfle@dhzc-charite.de', 'phone': '+49 (0)30-4593-2204'}, {'name': 'Michael Borger', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Herzzentrum Leipzig', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'city': 'Trumpington', 'state': 'Cambridge', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Patrick Calvert', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Royal Papworth Hospital NHS Foundation Trust', 'geoPoint': {'lat': 52.17214, 'lon': 0.11261}}, {'zip': 'LS9 7TF', 'city': 'Leeds', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Chris Malkin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Leeds Teaching Hospitals NHS Trust', 'geoPoint': {'lat': 53.79648, 'lon': -1.54785}}, {'city': 'Whitechapel', 'state': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Dincer Aktuerk', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Barts Health NHS Trust', 'geoPoint': {'lat': 51.51382, 'lon': -0.06583}}, {'city': 'Oxford', 'state': 'Manchester', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Mamta Buch', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Manchester University NHS Foundation Trust', 'geoPoint': {'lat': 51.75222, 'lon': -1.25596}}, {'city': 'Marton-in-Cleveland', 'state': 'Middlesbrough', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Enoch Akowuah, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'South Tees Hospitals NHS Foundation Trust', 'geoPoint': {'lat': 54.5291, 'lon': -1.20257}}, {'zip': 'OX3 9DU', 'city': 'Oxford', 'state': 'Oxfordshire', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Rana Sayeed', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Oxford University Hospitals NHS Foundation Trust', 'geoPoint': {'lat': 51.75222, 'lon': -1.25596}}, {'zip': 'BN11 2DH', 'city': 'Worthing', 'state': 'West Sussex', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Louise Steel', 'role': 'CONTACT', 'email': 'louise.steel7@nhs.net'}, {'name': 'Ish Ahmed', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University Hospitals Sussex NHS Foundation Trust', 'geoPoint': {'lat': 50.81795, 'lon': -0.37538}}], 'centralContacts': [{'name': 'Chari Ponder, RN, BSN', 'role': 'CONTACT', 'email': 'chari.ponder@mountsinai.org', 'phone': '(646) 899-8106'}, {'name': 'Jonathan Hupf', 'role': 'CONTACT', 'email': 'Jonathan.Hupf@mountsinai.org', 'phone': '(646) 385-0854'}], 'overallOfficials': [{'name': 'Joanna Chikwe, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Cedars-Sinai'}, {'name': 'Martin Leon, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Columbia University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO', 'description': 'Data shared will be in aggregate.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Annetine Gelijns', 'class': 'OTHER'}, 'collaborators': [{'name': 'National Heart, Lung, and Blood Institute (NHLBI)', 'class': 'NIH'}], 'responsibleParty': {'type': 'SPONSOR_INVESTIGATOR', 'investigatorTitle': 'Department Chair, Department of Population Health Science & Policy Edmond A. Guggenheim Professor of Health Policy Co-Director, InCHOIR', 'investigatorFullName': 'Annetine Gelijns', 'investigatorAffiliation': 'Icahn School of Medicine at Mount Sinai'}}}}